Feature Updates

Master Bull's Eye Chart in Five Minutes, Make Your Report Stand Out!

18 January 2024
2 min read

In this update of Synapse, we have introduced a bull's-eye chart display feature that supports a drug analysis view and detailed pages for competitive landscapes (including targets/indications/drug types), which are presented in a bull's-eye chart format.

The Bullseye Chart presents a variety of information in a relatively compact manner while also showcasing the hierarchical nature of data, aiding you in effortlessly depicting competitive dynamics.

Take the following GLP-1R drug competitive landscape as an example: each concentric circle represents a stage of research and development, each sector corresponds to a pharmaceutical research institution, and each dot represents a different drug. Different colors indicate different types of drugs. By hovering the mouse over a point, you can view basic information about the drug. This chart reveals that Eli Lilly is currently a leader in the GLP-1 field, with three GLP-1 drugs approved for the market, namely exenatide, dulaglutide, and tirzepatide.

How to Design a Bull's Eye Chart Using Synapse in Five Minutes

Using the competitive landscape of non-small cell lung cancer as an example, let's experience how to customize the analysis charts you need in 5 minutes. First, enter "non-small cell lung cancer" in the search bar of the Synapse database, and click to view the details.

图形用户界面, 文本, 应用程序

描述已自动生成

Upon entering the non-small cell lung cancer (NSCLC) details page, we can view a bulls-eye chart categorized by dimensions such as R&D institutions, targets, drug types, and geographical regions. By hovering the mouse over a data point, detailed data information can be accessed.

Click on the upper-right corner for the drug development phase to select a specific stage for graphical data presentation. You can also use the shortcut buttons for drug categories at the top to choose to display or hide specific drug categories.

图表

低可信度描述已自动生成

More granular chart display requirements can be filtered through the filter bar in the top-left corner.

图片包含 图表

描述已自动生成

With this approach, a clear and precise bullseye chart has been customized. The export and fullscreen buttons located at the top right corner facilitate the downloading and viewing of the image.

图表

描述已自动生成

Similarly, you can customize a Bullseye Chart for categories such as targets/drug types etc., following the steps mentioned above.

Come experience the Bull's-eye plot in the Synapse database and add it to your report!

Biological Glossary | What is Terminator?
Bio Sequence
2 min read
Biological Glossary | What is Terminator?
18 January 2024
In biology, a terminator is a sequence of nucleotides that marks the end of a gene or operon during the transcription process.
Read →
Aclaris Pharma Shares Initial Outcomes after a Month-Long Phase 2b Study on ATI-1777 in Treating Mild to Intense Eczema
Latest Hotspot
3 min read
Aclaris Pharma Shares Initial Outcomes after a Month-Long Phase 2b Study on ATI-1777 in Treating Mild to Intense Eczema
18 January 2024
Aclaris Therapeutics, working on immune-related treatments, shared initial Phase 2b results. They tested ATI-1777, a new topical JAK 1/3 inhibitor, on atopic dermatitis patients.
Read →
What is a placebo in clinical trials?
"What" Series
2 min read
What is a placebo in clinical trials?
17 January 2024
In clinical trials, a placebo is an inactive substance or other intervention that looks the same and tastes the same as the active drug being tested.
Read →
EyePoint Pharma announces first patient treatment in early-phase VERONA trial for EYP-1901 in diabetic eye swelling
Latest Hotspot
3 min read
EyePoint Pharma announces first patient treatment in early-phase VERONA trial for EYP-1901 in diabetic eye swelling
17 January 2024
EyePoint Pharma reports initial participant receives treatment in early-stage VERONA study assessing EYP-1901 for diabetic eye swelling.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.